Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Latest round
Venture round
Jul 2025 · 14 mo ago
Team
51-200
employees, estimated range
The money's age
Due for its next round
14 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 24, 2025 Raised a round Venture round Jun 9, 2022 Raised a round Venture round Apr 30, 2021 Raised a round Venture round Jan 8, 2020 Raised a round Venture round Jul 12, 2019 Raised a round Venture round Feb 27, 2019 Raised a round Venture round Sep 24, 2018 Raised a round Venture round Jul 4, 2017 Raised a round Venture round Oct 10, 2016 Raised a round Venture round Dec 21, 2015 Raised a round Venture round Feb 10, 2015 Founded per the company register
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jul 2025 — — find-and-update.company-information.service.gov.uk
Venture round Jun 2022 — — find-and-update.company-information.service.gov.uk
Venture round Apr 2021 — — find-and-update.company-information.service.gov.uk
Venture round Jan 2020 — — find-and-update.company-information.service.gov.uk
Venture round Jul 2019 — — find-and-update.company-information.service.gov.uk
Venture round Feb 2019 — — find-and-update.company-information.service.gov.uk
Venture round Sep 2018 — — find-and-update.company-information.service.gov.uk
Venture round Jul 2017 — — find-and-update.company-information.service.gov.uk
Venture round Oct 2016 — — find-and-update.company-information.service.gov.uk
Venture round Dec 2015 — — find-and-update.company-information.service.gov.uk
Registers and programsofficial lists and records that name the company
Legal entity AMO PHARMA LIMITED Companies House
Registered 10 Feb 2015
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Repair BiotechnologiesVenture round $5.3M · 10 mo ago • Founded 2018 • 51-200 employees
Human cells cannot degrade cholesterol, leading to several chronic and orphan diseases. Repair Biotechnologies’ Cholesterol Degrading…
GEn1E LifesciencesVenture round $5.5M · 11 mo ago • Founded 2018 • 51-200 employees
US FDA Grants Orphan Drug and Rare Pediatric Disease Designations to GEn1E Lifesciences' Dual Signal Modulator for the Treatment of…
Mendra window11-50 employees
Mendra is a venture-backed rare-disease biopharma accelerating the development and commercialization of de-risked breakthrough therapies.
Noema PharmaSeries B · 23 mo ago • Founded 2019 • 11-50 employees • 1 role
Noema Pharma is a biotech company developing therapies for the most disabling symptoms of orphan conditions of the brain and nervous…
MinoryxVenture round $55.1M · 4 yr ago • 51-200 employees
Minoryx is focused on the discovery and development of novel treatments for severe, orphan diseases of the central nervous system with high…
Autobahn aims to improve life health for people affected by CNS disorders by driving the regenerative power of the human body.

Overview

AMO Pharma is dedicated to making a positive difference for people affected by serious and debilitating diseases, particularly rare or orphan diseases.

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Leeds United Kingdom
HQ
London United Kingdom
Regional office
London UK Office
company site

Financials

Latest round
Venture - Series Unknown
Funding rounds
10
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 — Details
Venture - Series Unknown 2022 — Details
Venture - Series Unknown 2021 — Details
Venture - Series Unknown 2020 — Details
Venture - Series Unknown 2019 — Details
Venture - Series Unknown 2019 — Details
Venture - Series Unknown 2018 — Details
Venture - Series Unknown 2017 — Details
Venture - Series Unknown 2016 — Details
Venture - Series Unknown 2015 — Details